{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:26:21Z","timestamp":1793406381269,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genom Data"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Resistance to carbapenems and third-generation cephalosporins is increasing in\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      globally, restricting therapeutic options. The \u03b2-lactam\/\u03b2-lactamase inhibitor combinations are widely used to circumvent \u03b2-lactamase-mediated resistance. In 2021, an unusual\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      clinical isolate, KpMVR1, was recovered from a hospitalised patient in England, exhibiting resistance to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam. To investigate this phenomenon, we characterised the genome and antimicrobial susceptibility of KpMVR1 alongside two clonally related isolates susceptible to all three \u03b2-lactam\/\u03b2-lactamase inhibitor combinations: KpMVS1, collected from the same patient 42\u2009days earlier, and KpMVS2, from another patient in the same hospital.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Illumina and MinION whole-genome sequencing were conducted for these three isolates, followed by hybrid genome assembly. Annotated genome assemblies were compared to identify genetic variation. Mutagenesis experiments were performed to verify predicted functional alterations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All isolates belonged to clone ST8134 and carried\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC-2<\/jats:sub>\n                      alleles (KpMVR1:\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC-157<\/jats:sub>\n                      ; KpMVS1 and KpMVS2:\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC-2<\/jats:sub>\n                      ) in plasmids predicted to be conjugative. Insertion sequence IS\n                      <jats:italic>Ec68<\/jats:italic>\n                      caused a frameshift mutation in KpMVR1\u2019s\n                      <jats:italic>ompK36<\/jats:italic>\n                      gene, reducing susceptibility to meropenem-vaborbactam and imipenem-relebactam. KPC-157 demonstrated decreased hydrolysis of imipenem and ceftazidime when compared with KPC-2. KpMVR1 also encoded a disrupted transcriptional repressor MarR and a destabilising mutation in AcrB, a component of the AcrAB-TolC multidrug efflux pump. An intact, iron-transporting\n                      <jats:italic>fec<\/jats:italic>\n                      operon was identified on a novel IncFII(pKP91)\/IncFIB(K) plasmid unique to KpMVS2, possibly accounting for the cefiderocol resistance observed in this isolate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>KpMVR1 carried multiple resistance-associated genetic alterations and likely developed its resistance profile through within-patient evolution. This study highlights the importance of routine screening for resistant pathogens in vulnerable patients to guide antimicrobial chemotherapy and the need to characterise underlying resistance mechanisms to assess the risk of onward dissemination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12863-026-01421-x","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:25:51Z","timestamp":1778315151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam"],"prefix":"10.1186","volume":"27","author":[{"given":"Yu","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L. C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sanchez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Wen","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane F.","family":"Turton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Morecchiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Baccani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Dodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elita","family":"Jauneikaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","volume":"68","author":"CM Baldwin","year":"2008","unstructured":"Baldwin CM, Lyseng-Williamson KA, Keam SJ. Meropenem. Drugs. 2008;68:803\u201338. https:\/\/doi.org\/10.2165\/00003495-200868060-00006.","journal-title":"Drugs"},{"key":"1421_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s15010-019-01291-9","volume":"47","author":"S Meini","year":"2019","unstructured":"Meini S, Tascini C, Cei M, Sozio E, Rossolini GM. AmpC \u03b2-lactamase-producing Enterobacterales: what a clinician should know. Infection. 2019;47:363\u201375. https:\/\/doi.org\/10.1007\/s15010-019-01291-9.","journal-title":"Infection"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01857.x","volume":"14","author":"DM Livermore","year":"2008","unstructured":"Livermore DM. Defining an extended-spectrum \u03b2-lactamase. Clin Microbiol Infect. 2008;14:3\u201310. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01857.x.","journal-title":"Clin Microbiol Infect"},{"key":"1421_CR4","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VHA, Takebayashi Y, et al. \u03b2-Lactamases and \u03b2-lactamase inhibitors in the 21st century. J Educ Chang Mol Biol. 2019;431:3472\u2013500. https:\/\/doi.org\/10.1016\/j.jmb.2019.04.002.","journal-title":"J Educ Chang Mol Biol"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/cmr.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA. AmpC \u03b2-lactamases. Clin Microbiol Rev. 2009;22:161\u201382. https:\/\/doi.org\/10.1128\/cmr.00036-08.","journal-title":"Clin Microbiol Rev"},{"key":"1421_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/phar.2092","volume":"38","author":"SCJ Jorgensen","year":"2018","unstructured":"Jorgensen SCJ, Rybak MJ. Meropenem and Vaborbactam: stepping up the battle against Carbapenem-resistant Enterobacteriaceae. Pharmacother J Hum Pharmacol Drug Ther. 2018;38:444\u201361. https:\/\/doi.org\/10.1002\/phar.2092.","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"1421_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jac\/dkl354","volume":"58","author":"AC Rodloff","year":"2006","unstructured":"Rodloff AC, Goldstein EJC, Torres A. Two decades of imipenem therapy. The J Antimicrob Chemother. 2006;58:916\u201329. https:\/\/doi.org\/10.1093\/jac\/dkl354.","journal-title":"The J Antimicrob Chemother"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1021\/acs.chemrev.0c01213","volume":"121","author":"JD Prajapati","year":"2021","unstructured":"Prajapati JD, Kleinekath\u00f6fer U, Winterhalter M. How to enter a bacterium: bacterial porins and the permeation of antibiotics. Chem Rev. 2021;121:5158\u201392. https:\/\/doi.org\/10.1021\/acs.chemrev.0c01213.","journal-title":"Chem Rev"},{"key":"1421_CR9","doi-asserted-by":"publisher","unstructured":"Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson K, Tsivkovski R, Griffith DC, et al. Vaborbactam: spectrum of Beta-lactamase Inhibition and Impact of resistance mechanisms on activity in Enterobacteriaceae. Antimicrob Agents Chemother. 2017;61:10.1128\/aac.01443\u201317. https:\/\/doi.org\/10.1128\/aac.01443-17.","DOI":"10.1128\/aac.01443-17"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"27960","DOI":"10.1074\/jbc.M113.485979","volume":"288","author":"DE Ehmann","year":"2013","unstructured":"Ehmann DE, Jahi\u0107 H, Ross PL, Gu R-F, Hu J, Durand-R\u00e9ville TF, et al. Kinetics of avibactam inhibition against class A, C, and D \u03b2-lactamases. J Biol Chem. 2013;288:27960\u201371. https:\/\/doi.org\/10.1074\/jbc.M113.485979.","journal-title":"J Biol Chem"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/antibiotics10080995","volume":"10","author":"D Carcione","year":"2021","unstructured":"Carcione D, Siracusa C, Sulejmani A, Leoni V, Intra J. Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use. Antibiotics. 2021;10:995. https:\/\/doi.org\/10.3390\/antibiotics10080995.","journal-title":"Antibiotics"},{"key":"1421_CR12","unstructured":"National Institute for Health and Care Excellence. Antimicrobial prescribing: meropenem with vaborbactam (Evidence summary [ES21]). National Institute for Health and Care Excellence (NICE). 2019. https:\/\/www.nice.org.uk\/advice\/es21\/chapter\/Key-messages."},{"key":"1421_CR13","unstructured":"National Institute for Health and Care Excellence. Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections (Health technology evaluation [HTE1]). National Institute for Health and Care Excellence (NICE). 2022. https:\/\/www.nice.org.uk\/guidance\/hte1\/chapter\/1-Recommendations."},{"key":"1421_CR14","unstructured":"National Institute for Health and Care Excellence. Antimicrobial prescribing: imipenem with cilastatin and relebactam (evidence summary [ES30]). National Institute for Health and Care Excellence (NICE). 2020. https:\/\/www.nice.org.uk\/advice\/es30\/evidence."},{"key":"1421_CR15","doi-asserted-by":"publisher","first-page":"2400399","DOI":"10.2807\/1560-7917.ES.2025.30.14.2400399","volume":"30","author":"RL Guy","year":"2025","unstructured":"Guy RL, Hopkins KL, Budd EL, Wilson K, Fountain H, Meunier D, et al. The importance of monitoring a new antibiotic: ceftazidime\/avibactam usage and resistance experience from England & comma; 2016 to 2020. Eurosurveillance. 2025;30:2400399. https:\/\/doi.org\/10.2807\/1560-7917.ES.2025.30.14.2400399.","journal-title":"Eurosurveillance"},{"key":"1421_CR16","doi-asserted-by":"publisher","unstructured":"Reynolds R, Mushtaq S, Hope R, Horner C, Adkin R, Chaudhry A, et al. Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019. J Antimicrob Chemother. 2025;80(Suppl_4):iv36\u201348. https:\/\/doi.org\/10.1093\/jac\/dkaf250.","DOI":"10.1093\/jac\/dkaf250"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/antibiotics11111621","volume":"11","author":"F Bovo","year":"2022","unstructured":"Bovo F, Lombardo D, Lazzarotto T, Ambretti S, Gaibani P. Epidemiology and in vitro activity of ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam against KPC-producing K. pneumoniae collected from bacteremic patients, 2018 to 2020. Antibiotics. 2022;11:1621. https:\/\/doi.org\/10.3390\/antibiotics11111621.","journal-title":"Antibiotics"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s15010-021-01735-1","volume":"50","author":"S Maraki","year":"2022","unstructured":"Maraki S, Mavromanolaki VE, Magkafouraki E, Moraitis P, Stafylaki D, Kasimati A, et al. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates. Infection. 2022;50:467\u201374. https:\/\/doi.org\/10.1007\/s15010-021-01735-1.","journal-title":"Infection"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"115945","DOI":"10.1016\/j.diagmicrobio.2023.115945","volume":"106","author":"HS Sader","year":"2023","unstructured":"Sader HS, Mendes RE, Duncan L, Kimbrough JH, Carvalhaes CG, Castanheira M. Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022). Diagn Microbiol Infect Dis. 2023;106:115945. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.115945.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1421_CR20","doi-asserted-by":"publisher","unstructured":"Bovo F, Amadesi S, Palombo M, Lazzarotto T, Ambretti S, Gaibani P. Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam co-producing KPC and OXA-181 carbapenemase. JAC Antimicrob Resist. 2023;5:dlad099. https:\/\/doi.org\/10.1093\/jacamr\/dlad099.","DOI":"10.1093\/jacamr\/dlad099"},{"key":"1421_CR21","doi-asserted-by":"publisher","unstructured":"Paolo G, Gabriele B, Stefano A, Matteo B, Simone A, Cristina C. Increased blaKPC copy number and OmpK35 and OmpK36 porins disruption mediated resistance to Imipenem\/Relebactam and Meropenem\/Vaborbactam in a KPC-Producing Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother. 2022;66:e00191\u201322. https:\/\/doi.org\/10.1128\/aac.00191-22.","DOI":"10.1128\/aac.00191-22"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12866-021-02293-0","volume":"21","author":"L Sun","year":"2021","unstructured":"Sun L, Li H, Wang Q, Liu Y, Cao B. Increased gene expression and copy number of mutated blaKPC lead to high-level ceftazidime\/avibactam resistance in Klebsiella pneumoniae. BMC Microbiol. 2021;21:230. https:\/\/doi.org\/10.1186\/s12866-021-02293-0.","journal-title":"BMC Microbiol"},{"key":"1421_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/antibiotics11050628","volume":"11","author":"P Gaibani","year":"2022","unstructured":"Gaibani P, Giani T, Bovo F, Lombardo D, Amadesi S, Lazzarotto T, et al. Resistance to Ceftazidime\/Avibactam, Meropenem\/Vaborbactam and Imipenem\/Relebactam in Gram-negative MDR bacilli: molecular mechanisms and susceptibility Testing. Antibiotics. 2022;11:628. https:\/\/doi.org\/10.3390\/antibiotics11050628.","journal-title":"Antibiotics"},{"key":"1421_CR24","doi-asserted-by":"publisher","unstructured":"Jacqueline F, Laurent P, Mario J, Patrice N. KPC-Mediated resistance to ceftazidime-avibactam and collateral effects in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2021;65. https:\/\/doi.org\/10.1128\/aac.00890-21.","DOI":"10.1128\/aac.00890-21"},{"key":"1421_CR25","doi-asserted-by":"publisher","unstructured":"Rocker A, Lacey JA, Belousoff MJ, Wilksch JJ, Strugnell RA, Davies MR, et al. Global trends in proteome remodeling of the outer membrane modulate Antimicrobial permeability in Klebsiella pneumoniae. mBio. 2020;11. https:\/\/doi.org\/10.1128\/mbio.00603-20.","DOI":"10.1128\/mbio.00603-20"},{"key":"1421_CR26","doi-asserted-by":"publisher","unstructured":"Wilson WR, Kline EG, Jones CE, Morder KT, Mettus RT, Doi Y, et al. Effects of KPC variant and Porin Genotype on the in vitro activity of meropenem-vaborbactam against Carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2019;63. https:\/\/doi.org\/10.1128\/aac.02048-18.","DOI":"10.1128\/aac.02048-18"},{"key":"1421_CR27","doi-asserted-by":"publisher","unstructured":"Humphries Romney M, Peera H. Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3. Antimicrob Agents Chemother. 2017;61. https:\/\/doi.org\/10.1128\/aac.00537-17.","DOI":"10.1128\/aac.00537-17"},{"key":"1421_CR28","doi-asserted-by":"publisher","unstructured":"Rogers TM, Kline EG, Griffith MP, Jones CE, Rubio AM, Squires KM, et al. Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime\/avibactam, imipenem\/relebactam and meropenem\/vaborbactam against KPC-producing K. pneumoniae clinical isolates. JAC Antimicrob Resist. 2023;5:dlad022. https:\/\/doi.org\/10.1093\/jacamr\/dlad022.","DOI":"10.1093\/jacamr\/dlad022"},{"key":"1421_CR29","doi-asserted-by":"publisher","unstructured":"Punyawee D, Douglas Edward JA, Filip L, Avison Matthew B. Resistance to Ceftazidime\/Avibactam plus Meropenem\/Vaborbactam when both are used together is achieved in four steps in Metallo-\u03b2-lactamase-negative Klebsiella pneumoniae. Antimicrob Agents Chemother. 2020;64. https:\/\/doi.org\/10.1128\/aac.00409-20.","DOI":"10.1128\/aac.00409-20"},{"key":"1421_CR30","doi-asserted-by":"publisher","unstructured":"Naphat S, Punyawee D, Avison Matthew B. Klebsiella pneumoniae mutants resistant to ceftazidime-avibactam plus aztreonam, imipenem-relebactam, Meropenem-Vaborbactam, and cefepime-taniborbactam. Antimicrob Agents Chemother. 2022;66:e02179\u201321. https:\/\/doi.org\/10.1128\/aac.02179-21.","DOI":"10.1128\/aac.02179-21"},{"key":"1421_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1099\/jmm.0.000653","volume":"67","author":"JF Turton","year":"2018","unstructured":"Turton JF, Payne Z, Coward A, Hopkins KL, Turton JA, Doumith M, et al. Virulence genes in isolates of Klebsiella pneumoniae from the Uk during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and \u2018non-hypervirulent\u2019 types ST147, ST15 and ST383. J Med Microbiol. 2018;67:118\u201328. https:\/\/doi.org\/10.1099\/jmm.0.000653.","journal-title":"J Med Microbiol"},{"key":"1421_CR32","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints (V 15.0). 2025."},{"key":"1421_CR33","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics"},{"key":"1421_CR34","doi-asserted-by":"publisher","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"1421_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257. https:\/\/doi.org\/10.1186\/s13059-019-1891-0.","journal-title":"Genome Biol"},{"key":"1421_CR36","doi-asserted-by":"publisher","unstructured":"Lu J, Breitwieser FP, Thielen P, Salzberg SL. Bracken: estimating species abundance in metagenomics data. PeerJ Comput Sci. 2017;3:e104. https:\/\/doi.org\/10.7717\/peerj-cs.104.","DOI":"10.7717\/peerj-cs.104"},{"key":"1421_CR37","doi-asserted-by":"publisher","first-page":"001244","DOI":"10.1099\/mgen.0.001244","volume":"10","author":"G Bouras","year":"2024","unstructured":"Bouras G, Houtak G, Wick RR, Mallawaarachchi V, Roach MJ, Papudeshi B, et al. Hybracter: enabling scalable, automated, complete and accurate bacterial genome assemblies. Microb Genom. 2024;10:001244. https:\/\/doi.org\/10.1099\/mgen.0.001244.","journal-title":"Microb Genom"},{"key":"1421_CR38","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Additional File 1, PDF, Supplementary methods."},{"key":"1421_CR39","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41592-023-01940-w","volume":"20","author":"A Chklovski","year":"2023","unstructured":"Chklovski A, Parks DH, Woodcroft BJ, Tyson GW. CheckM2: a rapid, scalable and accurate tool for assessing microbial genome quality using machine learning. Nat Methods. 2023;20:1203\u201312. https:\/\/doi.org\/10.1038\/s41592-023-01940-w.","journal-title":"Nat Methods"},{"key":"1421_CR40","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/bioinformatics\/btx699","volume":"34","author":"BS Pedersen","year":"2018","unstructured":"Pedersen BS, Quinlan AR. Mosdepth: quick coverage calculation for genomes and exomes. Bioinformatics. 2018;34:867\u201368. https:\/\/doi.org\/10.1093\/bioinformatics\/btx699.","journal-title":"Bioinformatics"},{"key":"1421_CR41","doi-asserted-by":"publisher","first-page":"000685","DOI":"10.1099\/mgen.0.000685","volume":"7","author":"O Schwengers","year":"2021","unstructured":"Schwengers O, Jelonek L, Dieckmann MA, Beyvers S, Blom J, Goesmann A. Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification. Microb Genomics. 2021;7:000685. https:\/\/doi.org\/10.1099\/mgen.0.000685.","journal-title":"Microb. Genomics"},{"key":"1421_CR42","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1038\/s41467-021-24448-3","volume":"12","author":"MMC Lam","year":"2021","unstructured":"Lam MMC, Wick RR, Watts SC, Cerdeira LT, Wyres KL, Holt KE. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat Commun. 2021;12:4188. https:\/\/doi.org\/10.1038\/s41467-021-24448-3.","journal-title":"Nat Commun"},{"key":"1421_CR43","doi-asserted-by":"publisher","unstructured":"Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R, Thomson NR, et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genomics. 2016;2:e000102. https:\/\/doi.org\/10.1099\/mgen.0.000102.","DOI":"10.1099\/mgen.0.000102"},{"key":"1421_CR44","doi-asserted-by":"publisher","first-page":"12728","DOI":"10.1038\/s41598-021-91456-0","volume":"11","author":"M Feldgarden","year":"2021","unstructured":"Feldgarden M, Brover V, Gonzalez-Escalona N, Frye JG, Haendiges J, Haft DH, et al. AMRFinderPlus and the Reference gene catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci Rep. 2021;11:12728. https:\/\/doi.org\/10.1038\/s41598-021-91456-0.","journal-title":"Sci Rep"},{"key":"1421_CR45","doi-asserted-by":"publisher","unstructured":"Couvin D, Bernheim A, Toffano-Nioche C, Touchon M, Michalik J, N\u00e9ron B, et al. CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins. Nucleic Acids Res. 2018;46:W246\u201351. https:\/\/doi.org\/10.1093\/nar\/gky425.","DOI":"10.1093\/nar\/gky425"},{"key":"1421_CR46","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1128\/aac.02412-14","volume":"58","author":"A Carattoli","year":"2014","unstructured":"Carattoli A, Zankari E, Garc\u00eda-Fern\u00e1ndez A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58:3895\u2013903. https:\/\/doi.org\/10.1128\/aac.02412-14.","journal-title":"Antimicrob Agents Chemother"},{"key":"1421_CR47","doi-asserted-by":"publisher","unstructured":"Robertson J, Nash JHE. MOB-suite: software tools for clustering, reconstruction and typing of plasmids from draft assemblies. Microb Genom. 2018;4. https:\/\/doi.org\/10.1099\/mgen.0.000206.","DOI":"10.1099\/mgen.0.000206"},{"key":"1421_CR48","doi-asserted-by":"publisher","unstructured":"Karen R, Varani Alessandro M, Erik S, Hongzhan H, Oliveira AD, Jian Z, et al. TnCentral: a prokaryotic transposable element database and web portal for transposon analysis. mBio. 2021;12. https:\/\/doi.org\/10.1128\/mbio.02060-21.","DOI":"10.1128\/mbio.02060-21"},{"key":"1421_CR49","doi-asserted-by":"publisher","unstructured":"Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. Isfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34(suppl_1):D32\u20136. https:\/\/doi.org\/10.1093\/nar\/gkj014.","DOI":"10.1093\/nar\/gkj014"},{"key":"1421_CR50","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094\u2013100. https:\/\/doi.org\/10.1093\/bioinformatics\/bty191.","journal-title":"Bioinformatics"},{"key":"1421_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff. Fly. 2012;6:80\u201392. https:\/\/doi.org\/10.4161\/fly.19695.","journal-title":"Fly"},{"key":"1421_CR52","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang H-Y, Fraser M, Li W, McAnulla C, et al. InterProScan, 5: genome-scale protein function classification. Bioinformatics. 2014;30:1236\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btu031.","journal-title":"Bioinformatics"},{"key":"1421_CR53","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.jmb.2019.04.009","volume":"431","author":"S Ittisoponpisan","year":"2019","unstructured":"Ittisoponpisan S, Islam SA, Khanna T, Alhuzimi E, David A, Sternberg MJE. Can predicted protein 3D structures provide reliable insights into whether missense variants are disease associated? J Educ Chang Mol Biol. 2019;431:2197\u2013212. https:\/\/doi.org\/10.1016\/j.jmb.2019.04.009.","journal-title":"J Educ Chang Mol Biol"},{"key":"1421_CR54","doi-asserted-by":"publisher","unstructured":"The UniProt Consortium. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506\u201315. https:\/\/doi.org\/10.1093\/nar\/gky1049.","DOI":"10.1093\/nar\/gky1049"},{"key":"1421_CR55","doi-asserted-by":"publisher","unstructured":"Zhou Y, Pan Q, Pires DEV, Rodrigues CHM, Ascher DB. Ddmut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res. 2023;51:W122\u20138. https:\/\/doi.org\/10.1093\/nar\/gkad472.","DOI":"10.1093\/nar\/gkad472"},{"key":"1421_CR56","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/s41564-022-01146-4","volume":"7","author":"WW Low","year":"2022","unstructured":"Low WW, Wong JLC, Beltran LC, Seddon C, David S, Kwong H-S, et al. Mating pair stabilization mediates bacterial conjugation species specificity. Nat Microbiol. 2022;7:1016\u201327. https:\/\/doi.org\/10.1038\/s41564-022-01146-4.","journal-title":"Nat Microbiol"},{"key":"1421_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2164-12-402","volume":"12","author":"N-F Alikhan","year":"2011","unstructured":"Alikhan N-F, Petty NK, Ben Zakour NL, Beatson SA. BLAST ring image generator (BRIG): simple prokaryote genome comparisons. BMC Genomics. 2011;12:402. https:\/\/doi.org\/10.1186\/1471-2164-12-402.","journal-title":"BMC Genomics"},{"key":"1421_CR58","doi-asserted-by":"publisher","unstructured":"Grant JR, Enns E, Marinier E, Mandal A, Herman EK, Chen C, et al. Proksee: in-depth characterization and visualization of bacterial genomes. Nucleic Acids Res. 2023;51:W484\u201392. https:\/\/doi.org\/10.1093\/nar\/gkad326.","DOI":"10.1093\/nar\/gkad326"},{"key":"1421_CR59","unstructured":"Wilkins D, Kurtz Z. gggenes. https:\/\/wilkox.org\/gggenes\/."},{"key":"1421_CR60","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/s41467-019-11756-y","volume":"10","author":"JLC Wong","year":"2019","unstructured":"Wong JLC, Romano M, Kerry LE, Kwong H-S, Low W-W, Brett SJ, et al. OmpK36-mediated carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo. Nat Commun. 2019;10:3957. https:\/\/doi.org\/10.1038\/s41467-019-11756-y.","journal-title":"Nat Commun"},{"key":"1421_CR61","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41587-021-01156-3","volume":"40","author":"F Teufel","year":"2022","unstructured":"Teufel F, Almagro Armenteros JJ, Johansen AR, G\u00edslason MH, Pihl SI, Tsirigos KD, et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol. 2022;40:1023\u201325. https:\/\/doi.org\/10.1038\/s41587-021-01156-3.","journal-title":"Nat Biotechnol"},{"key":"1421_CR62","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. MIC determination of non-fastidious and fastidious organisms. https:\/\/www.eucast.org\/ast_of_bacteria\/mic_determination."},{"key":"1421_CR63","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Guidance document on broth microdilution testing of cefiderocol. 2024."},{"key":"1421_CR64","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1021\/bi700300u","volume":"46","author":"W Ke","year":"2007","unstructured":"Ke W, Bethel CR, Thomson JM, Bonomo RA, van den Akker F. Crystal structure of KPC-2: insights into carbapenemase activity in class a \u03b2-lactamases. Biochemistry. 2007;46:5732\u201340. https:\/\/doi.org\/10.1021\/bi700300u.","journal-title":"Biochemistry"},{"key":"1421_CR65","doi-asserted-by":"publisher","first-page":"106935","DOI":"10.1016\/j.ijantimicag.2023.106935","volume":"62","author":"E Gato","year":"2023","unstructured":"Gato E, Guijarro-S\u00e1nchez P, Alonso-Garc\u00eda I, Pedraza-Merino R, Conde A, Lence E, et al. In vitro development of imipenem\/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification. Int J Antimicrob Agents. 2023;62:106935. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106935.","journal-title":"Int J Antimicrob Agents"},{"key":"1421_CR66","doi-asserted-by":"publisher","unstructured":"Krishnan NP, Nguyen NQ, Papp-Wallace KM, Bonomo RA, van den Akker F. Inhibition of Klebsiella \u03b2-lactamases (SHV-1 and KPC-2) by avibactam: a structural study. PLoS One. 2015;10:e0136813. https:\/\/doi.org\/10.1371\/journal.pone.0136813.","DOI":"10.1371\/journal.pone.0136813"},{"key":"1421_CR67","doi-asserted-by":"publisher","unstructured":"Pemberton Orville A, Ruslan T, Maxim T, Olga L, Yu C. Structural basis and binding kinetics of vaborbactam in class a \u03b2-lactamase inhibition. Antimicrob Agents Chemother. 2020;64. https:\/\/doi.org\/10.1128\/aac.00398-20.","DOI":"10.1128\/aac.00398-20"},{"key":"1421_CR68","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Additional file 2, PDF, Supplementary figures."},{"key":"1421_CR69","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1128\/aac.01451-07","volume":"52","author":"N Thierry","year":"2008","unstructured":"Thierry N, Gaelle C, Maria-Virginia V, Marie-Fr\u00e9d\u00e9rique L, Quinn John P, Patrice N. Genetic structures at the origin of acquisition of the \u03b2-lactamase blaKPC gene. Antimicrob Agents Chemother. 2008;52:1257\u201363. https:\/\/doi.org\/10.1128\/aac.01451-07.","journal-title":"Antimicrob Agents Chemother"},{"key":"1421_CR70","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1128\/aac.05202-11","volume":"55","author":"C Gaelle","year":"2011","unstructured":"Gaelle C, Thierry N, Patrice N. Functional characterization of Tn4401, a Tn3-based transposon involved in blaKPC gene mobilization. Antimicrob Agents Chemother. 2011;55:5370\u201373. https:\/\/doi.org\/10.1128\/aac.05202-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"1421_CR71","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Additional File 3, XSLX, Supplementary tables."},{"key":"1421_CR72","doi-asserted-by":"publisher","unstructured":"Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci India Sect B Biol Sci. 2015. https:\/\/doi.org\/10.1073\/pnas.1501049112.","DOI":"10.1073\/pnas.1501049112"},{"key":"1421_CR73","doi-asserted-by":"publisher","unstructured":"Tsang KK, Lam MMC, Wick RR, Wyres KL, Bachman M, Baker S, et al. Diversity, functional classification and genotyping of SHV \u03b2-lactamases in Klebsiella pneumoniae. 2024; 2024.04.05.587953. https:\/\/doi.org\/10.1101\/2024.04.05.587953.","DOI":"10.1101\/2024.04.05.587953"},{"key":"1421_CR74","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2147\/IDR.S251360","volume":"13","author":"Y Huang","year":"2020","unstructured":"Huang Y, Lin Q, Zhou Q, Lv L, Wan M, Gao X, et al. Identification of fosA10, a Novel plasmid-mediated fosfomycin resistance gene of Klebsiella pneumoniae Origin, in Escherichia coli. IDR. 2020;13:1273\u201379. https:\/\/doi.org\/10.2147\/IDR.S251360.","journal-title":"IDR"},{"key":"1421_CR75","doi-asserted-by":"publisher","first-page":"001102","DOI":"10.1099\/mgen.0.001102","volume":"9","author":"Y Wan","year":"2023","unstructured":"Wan Y, Sabnis A, Mumin Z, Potterill I, Jauneikaite E, Brown CS, et al. IS1-related large-scale deletion of chromosomal regions harbouring the oxygen-insensitive nitroreductase gene nfsB causes nitrofurantoin heteroresistance in Escherichia coli. Microb Genom. 2023;9:001102. https:\/\/doi.org\/10.1099\/mgen.0.001102.","journal-title":"Microb Genom"},{"key":"1421_CR76","doi-asserted-by":"publisher","unstructured":"Sato T, Yamawaki K. Cefiderocol: discovery, Chemistry, and in vivo profiles of a novel siderophore cephalosporin. Clin Infect Dis. 2019;69(Suppl_7):S538\u201343. https:\/\/doi.org\/10.1093\/cid\/ciz826.","DOI":"10.1093\/cid\/ciz826"},{"key":"1421_CR77","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1093\/jac\/dkac347","volume":"77","author":"K Kocer","year":"2022","unstructured":"Kocer K, Boutin S, Heeg K, Nurjadi D. The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in enterobacterales. J Antimicrob Chemother. 2022;77:3487\u201395. https:\/\/doi.org\/10.1093\/jac\/dkac347.","journal-title":"J Antimicrob Chemother"},{"key":"1421_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3201\/eid3101.241426","volume":"31","author":"R Polani","year":"2025","unstructured":"Polani R, De Francesco A, Tomolillo D, Artuso I, Equestre M, Trirocco R, et al. Cefiderocol resistance conferred by plasmid-located ferric citrate transport system in KPC-producing Klebsiella pneumoniae. Emerging Infect Dis J. 2025;31:123. https:\/\/doi.org\/10.3201\/eid3101.241426.","journal-title":"Emerging Infect Dis J"},{"key":"1421_CR79","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/107662903322286472","volume":"9","author":"F-J Chen","year":"2003","unstructured":"Chen F-J, Lauderdale T-L, Ho M, Lo H-J. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae. MICROB Drug Resist. 2003;9:265\u201371. https:\/\/doi.org\/10.1089\/107662903322286472.","journal-title":"MICROB Drug Resist"},{"key":"1421_CR80","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/jac\/dkx270","volume":"72","author":"L Praski Alzrigat","year":"2017","unstructured":"Praski Alzrigat L, Huseby DL, Brandis G, Hughes D. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother. 2017;72:3016\u201324. https:\/\/doi.org\/10.1093\/jac\/dkx270.","journal-title":"J Antimicrob Chemother"},{"key":"1421_CR81","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0966-842X(01)02174-6","volume":"9","author":"H Mori","year":"2001","unstructured":"Mori H, Ito K. The sec protein-translocation pathway. Trends Microbiol. 2001;9:494\u2013500. https:\/\/doi.org\/10.1016\/S0966-842X(01)02174-6.","journal-title":"Trends Microbiol"},{"key":"1421_CR82","doi-asserted-by":"publisher","unstructured":"Malinverni Juliana C, Silhavy Thomas J. Assembly of outer membrane \u03b2-barrel proteins: the Bam complex. EcoSal Plus. 2011;4. https:\/\/doi.org\/10.1128\/ecosalplus.4.3.8.","DOI":"10.1128\/ecosalplus.4.3.8"},{"key":"1421_CR83","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Additional File 4, PNG, Original photo of the Coomassie-stained polyacrylamide gel electrophoresis illustrated in Figure 2c."},{"key":"1421_CR84","doi-asserted-by":"publisher","first-page":"8925","DOI":"10.1093\/nar\/gkad678","volume":"51","author":"G Frankel","year":"2023","unstructured":"Frankel G, David S, Low WW, Seddon C, Wong JLC, Beis K. Plasmids pick a bacterial partner before committing to conjugation. Nucleic Acids Res. 2023;51:8925\u201333. https:\/\/doi.org\/10.1093\/nar\/gkad678.","journal-title":"Nucleic Acids Res"},{"key":"1421_CR85","doi-asserted-by":"publisher","unstructured":"Low WW, Seddon C, Beis K, Frankel G. The interaction of the F-like plasmid-encoded TraN isoforms with their cognate outer membrane receptors. J Bacteriol. 2023;205:e00061-23. https:\/\/doi.org\/10.1128\/jb.00061-23.","DOI":"10.1128\/jb.00061-23"},{"key":"1421_CR86","unstructured":"UK Health Security Agency. UK Access, Watch, Reserve, and Other classification for antibiotics (UK-AWaRe antibiotic classification). 2025."},{"key":"1421_CR87","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1038\/s41467-024-49851-4","volume":"15","author":"E Sauerborn","year":"2024","unstructured":"Sauerborn E, Corredor NC, Reska T, Perlas A, Vargas da Fonseca Atum S, Goldman N, et al. Detection of hidden antibiotic resistance through real-time genomics. Nat Commun. 2024;15:5494. https:\/\/doi.org\/10.1038\/s41467-024-49851-4.","journal-title":"Nat Commun"},{"key":"1421_CR88","doi-asserted-by":"publisher","unstructured":"Fu Y, Zhang Y, Zhao J, Xie J, Kong H, Yang T, et al. Emergence of co-resistance to imipenem\/relebactam and ceftazidime\/avibactam in clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65 S130G\/P167S substitutions. Antimicrob Agents Chemother. 2025:e00891-25. https:\/\/doi.org\/10.1128\/aac.00891-25.","DOI":"10.1128\/aac.00891-25"},{"key":"1421_CR89","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11033-025-10801-y","volume":"52","author":"JPR Furlan","year":"2025","unstructured":"Furlan JPR, Bueno GC, Sousa-Carmo RR, Silva RLO, Barbosa MRF, and Sato MIZ, et al. KPC-157 and KPC-181 carbapenemases produced by Citrobacter freundii ST522 and Klebsiella pneumoniae ST258 isolated from wastewater. Mol Biol Rep. 2025;52:705. https:\/\/doi.org\/10.1007\/s11033-025-10801-y.","journal-title":"Mol Biol Rep"},{"key":"1421_CR90","doi-asserted-by":"publisher","unstructured":"Theuretzbacher U, Carrara E, Conti M, and Tacconelli E. Role of new antibiotics for KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2021;76(Suppl_1):i47\u201354. https:\/\/doi.org\/10.1093\/jac\/dkaa497.","DOI":"10.1093\/jac\/dkaa497"},{"key":"1421_CR91","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1128\/aac.04406-14","volume":"59","author":"M Papp-Wallace Krisztina","year":"2015","unstructured":"Papp-Wallace Krisztina M, Winkler Marisa L, Taracila Magdalena A, Bonomo Robert A. Variants of \u03b2-lactamase KPC-2 that are resistant to inhibition by avibactam. Antimicrol Agents Chemother. 2015;59:3710\u20137. https:\/\/doi.org\/10.1128\/aac.04406-14.","journal-title":"Antimicrol Agents Chemother"},{"key":"1421_CR92","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1089\/mdr.2019.0410","volume":"26","author":"L-T Wu","year":"2020","unstructured":"Wu L-T, Guo M-K, Ke S-C, Lin Y-P, Pang Y-C, and Nguyen H-TV, et al. Characterization of the genetic background of KPC-2-producing Klebsiella pneumoniae with insertion elements disrupting the ompK36 porin gene. Microb Drug Resist. 2020;26:1050\u20137. https:\/\/doi.org\/10.1089\/mdr.2019.0410.","journal-title":"Microb Drug Resist"},{"key":"1421_CR93","doi-asserted-by":"publisher","first-page":"105930","DOI":"10.1016\/j.ijantimicag.2020.105930","volume":"55","author":"M Hamel","year":"2020","unstructured":"Hamel M, Chatzipanagiotou S, Hadjadj L, Petinaki E, Papagianni S, Charalampaki N, et al. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017. Int J Antimicrob Agents. 2020;55:105930. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105930.","journal-title":"Int J Antimicrob Agents"},{"key":"1421_CR94","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1089\/mdr.2020.0514","volume":"27","author":"W Hayashi","year":"2021","unstructured":"Hayashi W, Iimura M, Soga E, Koide S, Izumi K, Yoshida S, et al. Presence of colistin- and tigecycline-resistant Klebsiella pneumoniae ST29 in municipal wastewater influents in Japan. Microb Drug Resist. 2021;27:1433\u201342. https:\/\/doi.org\/10.1089\/mdr.2020.0514.","journal-title":"Microb Drug Resist"},{"key":"1421_CR95","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1128\/aac.40.2.342","volume":"40","author":"L Mart\u00ednez-Mart\u00ednez","year":"1996","unstructured":"Mart\u00ednez-Mart\u00ednez L, Hern\u00e1ndez-All\u00e9s S, Albert\u00ed S, Tom\u00e1s JM, Benedi VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins. Antimicrob Agents Chemother. 1996;40:342\u20138. https:\/\/doi.org\/10.1128\/aac.40.2.342.","journal-title":"Antimicrob Agents Chemother"},{"key":"1421_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/rvsc.2001.0537","volume":"72","author":"LP Randall","year":"2002","unstructured":"Randall LP, Woodward MJ. The multiple antibiotic resistance (mar) locus and its significance. Res Vet Sci. 2002;72:87\u201393. https:\/\/doi.org\/10.1053\/rvsc.2001.0537.","journal-title":"Res Vet Sci"},{"key":"1421_CR97","unstructured":"National Center for Biotechnology Information. https:\/\/www.ncbi.nlm.nih.gov.\u00a0"},{"key":"1421_CR98","unstructured":"Wan Y, Wong J, Sanchez-Garrido J, Low W, Turton J, Morecchiato F, et al. Full information on isolate KpMVR1 (id:75609). Institut Pasteur. https:\/\/bigsdb.pasteur.fr\/cgi-bin\/bigsdb\/bigsdb.pl?page=info%26db=pubmlst_klebsiella_isolates%26id=75609.\u00a0"},{"key":"1421_CR99","unstructured":"Klebsiella pneumoniae species complex. Institut Pasteur. https:\/\/bigsdb.pasteur.fr\/klebsiella\/."},{"key":"1421_CR100","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Full information on isolate KpMVS1 (id:75608). Institut Pasteur. https:\/\/bigsdb.pasteur.fr\/cgi-bin\/bigsdb\/bigsdb.pl?page=info%26db=pubmlst_klebsiella_isolates%26id=75608.\u00a0"},{"key":"1421_CR101","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Full information on isolate KpMVR1 (id:75609). Institut Pasteur. https:\/\/bigsdb.pasteur.fr\/cgi-bin\/bigsdb\/bigsdb.pl?page=info%26db=pubmlst_klebsiella_isolates%26id=75609.\u00a0"},{"key":"1421_CR102","unstructured":"Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton J, Morecchiato F, et al. Full information on isolate KpMVS2 (id:75610). Institut Pasteur. https:\/\/bigsdb.pasteur.fr\/cgi-bin\/bigsdb\/bigsdb.pl?page=info%26db=pubmlst_klebsiella_isolates%26id=75610.\u00a0"}],"container-title":["BMC Genomic Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12863-026-01421-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-026-01421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-026-01421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:45:11Z","timestamp":1779086711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12863-026-01421-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1186\/s12863-026-01421-x","relation":{},"ISSN":["2730-6844"],"issn-type":[{"value":"2730-6844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Following an internal review by the UKHSA Research Support and Governance Office (RSGO) it was agreed that this study fell outside the remit for ethics review. This decision was made based on the information provided to the RSGO and on the understanding that the study would be conducted in accordance with the conditions stated in the applicable UKHSA policies and procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}